Stock Taper 
GEHC
$71.72
▼ DOWN 1.04% (-0.76)
KEY STATISTICS
Market Cap$32.40 B
52w High$89.77
52w Low$58.75
Dividend Yield0.22%
FrequencyQuarterly
P/E15.73
Volume1.98M
Shares Out.451.69M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Peter J. Arduini
ABOUT
SECTOR
Healthcare
WENT PUBLIC
December 15, 2022
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
54,000
PRICE TARGET
Target High$90.00
Target Low$65.00
Target Median$80.00
Target Consensus$78.73
UPCOMING EARNINGS
DateNov 4, 2026
DayWednesday
Rev. Est.$5.35B
NOV
4
WED
PRICE
$71.72 ▼ DOWN 1.04% (−$0.76)About GE HealthCare Technologies Inc.
https://www.gehealthcare.com ↗GE HealthCare Technologies Inc. develops and markets medical imaging, ultrasound, patient care, and diagnostic solutions globally, serving hospitals and clinics across multiple segments including imaging, ultrasound, patient care, and pharmaceutic...
INDUSTRY
Medical - Devices
A PRODUCT GE HEALTHCARE TECHNOLOGIES INC. IS KNOWN FOR
SIGNA Sprint with Freelium
A helium-free, 1.5T MRI system with a sealed magnet that uses less than 1% of conventional helium, offering sustainable, high-quality imaging while addressing helium scarcity.
Revenue by Products
| Icon | PRODUCT | Q2-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Imaging Segment | $2.2B | $4.9B ▲ | $2.3B ▼ | — |
 | PDx Segment | $729M | $1.54B ▲ | $770M ▼ | $843M ▲ |
 | PCS Segment | $778M | $1.55B ▲ | $704M ▼ | $675M ▼ |
Revenue by Geography
| Map | REGION | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
 | Other Countries | $8.76B | $8.92B ▲ | $9.43B ▲ |
 | UNITED STATES | $8.23B | $8.62B ▲ | $9.17B ▲ |
 | CHINA | $2.56B | $2.13B ▼ | $2.03B ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
833
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
64.37%
HOLDERS
1,655
TOP 12 OF 1,655 · RANKED BY POSITION SIZE
Vanguard Group Inc
Dodge & Cox
Blackrock, Inc.
Blackrock Inc.
Capital Research Global Investors
State Street Corp
Invesco Ltd.
Harris Associates L P
Barrow Hanley Mewhinney & Strauss LLC
Geode Capital Management, LLC
Hotchkis & Wiley Capital Management LLC
Jpmorgan Chase & Co
RATINGS SNAPSHOT
Overall rating: B+
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book3
Overall Score3
TRADES BY CONGRESS
HOUSE TRADES
Ro Khanna
Purchase
2026-07-30
Gilbert Cisneros
Sale
2026-05-15
Terri Sewell
Sale
2026-03-25
Warren Davidson
Sale
2026-03-23
INSIDER TRADES
★
OFFICER: CHIEF PEOPLE OFFICER
Holton Adam Y
Sale · 1.4K shares
2026-08-15
★
DIRECTOR
Lobo Kevin
Purchase · 10.0K shares
2026-05-22
★
OFFICER: CEO, AIS
Rackliffe Philip
Purchase · 16.5K shares
2026-05-15
★
OFFICER: CEO, PATIENT CARE SOLUTIONS
Bankes Jeannette
Sale · 5.5K shares
2026-05-15
MOST RECENT ANALYST GRADES
GRADE SUMMARY
NEUTRAL 5
BUY 3
OVERWEIGHT 2
OUTPERFORM 2
EQUAL WEIGHT 2
14 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 CAH | $234.55 | COMPARE |
 HUM | $385.54 | COMPARE |
 A | $153.85 | COMPARE |
 IQV | $261.75 | COMPARE |
 ONC | $366.73 | COMPARE |
 ALC | $72.01 | COMPARE |
 RMD | $240.33 | COMPARE |
 MTD | $1398.58 | COMPARE |